- Page 1 and 2: National Health and Medical Researc
- Page 3: A HEALTHY START TO LIFE NHMRC is co
- Page 7 and 8: ABOUT THE REPORT This report was pr
- Page 9 and 10: PART1 OVERVIEW Chief Executive Offi
- Page 11 and 12: Structural review of NHMRC’s gran
- Page 13 and 14: During the year the NHMRC Council e
- Page 15 and 16: NHMRC’s strategy for health and m
- Page 17 and 18: RESEARCH FUNDING EXPENDITURE Fundin
- Page 19 and 20: PROMOTING EXCELLENCE THROUGH THE NH
- Page 21 and 22: Award Recipient Institution Researc
- Page 23 and 24: Award Recipient Institution Researc
- Page 25 and 26: CASE STUDY “This research is desi
- Page 27 and 28: ASSOCIATE PROFESSOR LEAH COSGROVE C
- Page 29 and 30: PROFESSOR LOUISA JORM WESTERN SYDNE
- Page 31 and 32: PART 2 PERFORMANCE REPORT Chief Exe
- Page 33 and 34: OUTCOMES AND PROGRAM STRUCTURE Thro
- Page 35 and 36: INVESTMENT Goal 5: Participate in d
- Page 37 and 38: TRANSLATION Goal 3: Develop public
- Page 39 and 40: INVESTMENT Create knowledge and bui
- Page 41 and 42: Table 3 Expenditure for Aboriginal
- Page 43 and 44: Figure 6 Expenditure by Science and
- Page 45 and 46: Targeted Calls for Research The out
- Page 47 and 48: GOAL 2: SUPPORT THE HEALTH AND MEDI
- Page 49 and 50: Table 11 People support outcomes fo
- Page 51 and 52: GOAL 3: BOOST DEMENTIA RESEARCH Boo
- Page 53 and 54: GOAL 4: SUPPORT COLLABORATIVE, MULT
- Page 55 and 56:
Target 4: Finalise collaborative re
- Page 57 and 58:
GOAL 6: SUPPORT RESEARCH THAT WILL
- Page 59 and 60:
GOAL 7: PROMOTE ACCESS TO AND USE O
- Page 61 and 62:
GOAL 8: IMPROVE THE GRANT APPLICATI
- Page 63 and 64:
TRANSLATION Support the translation
- Page 65 and 66:
NHMRC also established a separate a
- Page 67 and 68:
GOAL 2: SUPPORT THE TRANSLATION OF
- Page 69 and 70:
Target 6: Publish an updated Statem
- Page 71 and 72:
In early 2016, the NHMRC completed
- Page 73 and 74:
GOAL 3: DEVELOP PUBLIC AND ENVIRONM
- Page 75 and 76:
Public consultation will be underta
- Page 77 and 78:
GOAL 4: REMOVE BARRIERS TO COMMERCI
- Page 79 and 80:
Table 17 NHMRC commitments to resea
- Page 81 and 82:
Target 2: Improve processes for cli
- Page 83 and 84:
GOAL 1: RETAIN HIGH ETHICAL STANDAR
- Page 85 and 86:
GOAL 2: STRENGTHEN THE PROCESS FOR
- Page 87 and 88:
Outcome 2: Strengthen the process f
- Page 89 and 90:
Target 3: Review Ethical Guidelines
- Page 91 and 92:
GOAL 4: ADMINISTER THE RESEARCH INV
- Page 93 and 94:
PART 3 OPERATING ENVIRONMENT Legisl
- Page 95 and 96:
CORPORATE GOVERNANCE Governance bod
- Page 97 and 98:
• the Chief Medical Officer or th
- Page 99 and 100:
The ERLC assesses applications for
- Page 101 and 102:
EXTERNAL SCRUTINY JUDICIAL DECISION
- Page 103 and 104:
In accordance with the RMF: • the
- Page 105 and 106:
Table 19 Freedom of Information req
- Page 107 and 108:
ACCOUNTABILITY PURCHASING AND PROCU
- Page 109 and 110:
Table 21 Consultancy services let d
- Page 111 and 112:
Complaints and their outcomes Of th
- Page 113 and 114:
CORRECTION OF MATERIAL ERRORS IN PR
- Page 115 and 116:
CASE STUDY The team studied diaphra
- Page 117 and 118:
4 Part PEOPLE MANAGEMENT People 110
- Page 119 and 120:
Table 24 NHMRC employee overview as
- Page 121 and 122:
Consultations also raised the impor
- Page 123 and 124:
LEARNING AND DEVELOPMENT NHMRC’s
- Page 125 and 126:
Flexible workplace practices CASE S
- Page 127 and 128:
PART 5 FINANCIAL REPORT Financial P
- Page 129 and 130:
AGENCY RESOURCE STATEMENT Table 28
- Page 131 and 132:
INDEPENDENT AUDITOR’S REPORT To t
- Page 133 and 134:
PART 5 financial report Annual Repo
- Page 135 and 136:
Statement of Financial Position as
- Page 137 and 138:
Cash Flow Statement for the period
- Page 139 and 140:
Administered Reconciliation Schedul
- Page 141 and 142:
All new standards, amendments to st
- Page 143 and 144:
Reporting of Administered Activitie
- Page 145 and 146:
Income and Expenses Administered on
- Page 147 and 148:
Note 3.2 Non-Financial Assets Note
- Page 149 and 150:
Revaluations of non-financial asset
- Page 151 and 152:
Note 3.3 Other Payables 2016 2015 $
- Page 153 and 154:
Funding Note 5.1 Appropriations Not
- Page 155 and 156:
Note 5.3 Cash Flow Reconciliation R
- Page 157 and 158:
People and Relationships Note 6.1 P
- Page 159 and 160:
Managing Uncertainties Note 7.1 Con
- Page 161 and 162:
Note 7.2 Financial Instruments - Co
- Page 163 and 164:
Note 7.3 Administered - Financial I
- Page 165 and 166:
Other Information Note 8: Reporting
- Page 167 and 168:
6 PART APPENDICES Appendix 1: Execu
- Page 169 and 170:
Executive Director, Evidence, Advic
- Page 171 and 172:
CHAIR OF NHMRC COUNCIL Chair Profes
- Page 173 and 174:
Australian Capital Territory Dr Pau
- Page 175 and 176:
Professor Michael Kidd AM Member wi
- Page 177 and 178:
APPENDIX 3: RESEARCH COMMITTEE The
- Page 179 and 180:
APPENDIX 5: EMBRYO RESEARCH LICENSI
- Page 181 and 182:
APPENDIX 7: HEALTH INNOVATION ADVIS
- Page 183 and 184:
APPENDIX 9: PUBLIC CONSULTATIONS Pu
- Page 185 and 186:
IREG IRIISS JPco-fuND JPND MREA NAB
- Page 187 and 188:
PGPA Rule Reference Part of Report
- Page 189 and 190:
PGPA Rule Reference Part of Report
- Page 191 and 192:
PGPA Rule Reference Part of Report
- Page 193 and 194:
INDEX A Aboriginal and Torres Strai
- Page 195 and 196:
Cancer 5, 66 National Evidence Base
- Page 197:
S scholarships, 10, 39-41, 42 scien